Home LiteratureArticle Details
PMID: 6236231 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Increased efficiency of binding of nascent C3b to the erythrocytes of chronic cold agglutinin disease.

The Journal of clinical investigation ·Vol. 74 ·No. 3 ·1984-09-00 ·Pages 1050-62

Parker CJ, Soldato CM, Telen MJ

Abstract

The pathogenesis of chronic cold agglutinin disease (CCAD) has been enigmatic. To determine if abnormal erythrocyte membrane constituents might provide the stimulus for antibody production, we compared the electrophoretic pattern of radiolabeled membrane glycoproteins of four patients with CCAD to that of normal control erythrocytes. For the CCAD erythrocytes, fluorographs revealed the appearance of an abnormal band whose molecular weight was estimated at 126,000 D. Using two-dimensional gel analysis and immunoblotting techniques, it was determined that the 126,000 D glycoprotein consisted predominately of polymeric glycophorin-alpha. Previous investigations had suggested that abnormalities in glycophorin-alpha influence the functional activity of the complement system. When purified complement (C)3 was activated in the fluid-phase by cobra venom factor complexes, CCAD erythrocytes bound nascent C3b 7-27 times more efficiently than normal erythrocytes. Normal erythrocytes could be induced to manifest the appearance of the 126,000 D band, and the increased efficiency of binding of nascent C3b by incubation with CCAD serum or with the purified cold agglutinin antibody plus autologous serum, but not with the purified antibody alone or the purified antibody plus EDTA-chelated autologous serum. These studies demonstrate that the interactions of IgM cold-reacting antibody and complement with glycophorin induce changes in the biophysical properties of the erythrocyte membrane which modify subsequent interactions with complement.

MeSH Terms
Anemia, Hemolytic, Autoimmune/immunology Complement C3b/metabolism Erythrocyte Membrane/immunology Erythrocytes/immunology Glycophorins/isolation & purification Hemagglutination Tests Humans Immunoglobulin G/analysis Immunoglobulin M/analysis Membrane Proteins/blood,isolation & purification Molecular Weight Receptors, Complement/analysis,metabolism Receptors, Complement 3b Reference Values Sialoglycoproteins/isolation & purification
Chemicals
Glycophorins Immunoglobulin G Immunoglobulin M Membrane Proteins Receptors, Complement Receptors, Complement 3b Sialoglycoproteins Complement C3b
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Parker C J
Soldato C M
Telen M J
References (22)
22 references, click to expand
  1. The binding of activated C3 to polysaccharides and immunoglobulins.
    J Immunol. 1978 Dec;121(6):2566-72 PMID: 722084
  2. Abnormality of glycophorin-alpha on paroxysmal nocturnal hemoglobinuria erythrocytes.
    J Clin Invest. 1984 Apr;73(4):1130-43 PMID: 6231312
  3. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 PMID: 388439
  4. Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.
    J Immunol. 1980 Aug;125(2):634-9 PMID: 7391573
  5. Three rat monoclonal antibodies to human C3.
    Immunology. 1980 Nov;41(3):503-15 PMID: 6161872
  6. Chronic hemolytic anemia due to cold agglutinins: the mechanism of resistance of red cells to C' hemolysis by cold agglutinins.
    J Clin Invest. 1967 Sep;46(9):1461-74 PMID: 4166664
  7. Chronic hemolytic anemia due to cold agglutinins. II. The role of C' in red cell destruction.
    J Clin Invest. 1968 Apr;47(4):691-701 PMID: 5641611
  8. Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites.
    J Clin Invest. 1972 Mar;51(3):575-82 PMID: 4536807
  9. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    J Clin Invest. 1972 Mar;51(3):583-9 PMID: 4622104
  10. Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria.
    J Clin Invest. 1974 Jan;53(1):31-43 PMID: 4855546
  11. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man.
    J Clin Invest. 1974 Aug;54(2):339-48 PMID: 4847248
  12. The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man.
    J Clin Invest. 1976 Oct;58(4):942-9 PMID: 965497
  13. Biologic activity of cold-reacting autoantibodies (first of two parts).
    N Engl J Med. 1977 Sep 8;297(10):538-42 PMID: 69990
  14. Interaction between the third complement protein and cell surface macromolecules.
    Proc Natl Acad Sci U S A. 1977 Jul;74(7):2701-5 PMID: 268620
  15. Binding reaction between the third human complement protein and small molecules.
    Biochemistry. 1981 Dec 22;20(26):7457-63 PMID: 7326238
  16. Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria.
    J Clin Invest. 1982 Feb;69(2):337-46 PMID: 6915939
  17. Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.
    J Exp Med. 1982 Jul 1;156(1):205-16 PMID: 6177820
  18. Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity.
    J Immunol. 1982 Nov;129(5):2051-60 PMID: 6214588
  19. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    J Exp Med. 1983 Aug 1;158(2):334-52 PMID: 6224880
  20. Comparison of binding characteristics of factors B and H to C3b on normal and paroxysmal nocturnal hemoglobinuria erythrocytes.
    J Immunol. 1983 Nov;131(5):2484-9 PMID: 6226743
  21. Use of monoclonal anti-C3 antibodies to characterise the fragments of C3 that are found on erythrocytes.
    Vox Sang. 1983;45(5):367-72 PMID: 6605620
  22. Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces.
    J Immunol. 1979 Sep;123(3):1388-94 PMID: 38283
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1984-09-00
Pages
1050-62
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC425264
Subset
IM
Grants
PHS HHS · 1 R01 31379-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com